0001694665-22-000134.txt : 20221014
0001694665-22-000134.hdr.sgml : 20221014
20221014163241
ACCESSION NUMBER: 0001694665-22-000134
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220719
FILED AS OF DATE: 20221014
DATE AS OF CHANGE: 20221014
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zung Jonathan B.
CENTRAL INDEX KEY: 0001837972
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38473
FILM NUMBER: 221311662
MAIL ADDRESS:
STREET 1: C/O EVELO BIOSCIENCES, INC.
STREET 2: 620 MEMORIAL DRIVE, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evelo Biosciences, Inc.
CENTRAL INDEX KEY: 0001694665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465594527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 620 MEMORIAL DRIVE SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-577-0300
MAIL ADDRESS:
STREET 1: 620 MEMORIAL DRIVE SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_166577953055922.xml
FORM 4
X0306
4
2022-07-19
0
0001694665
Evelo Biosciences, Inc.
EVLO
0001837972
Zung Jonathan B.
C/O EVELO BIOSCIENCES, INC.
620 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
0
1
0
0
Chief Development Officer
Stock Option (Right to Buy)
2.24
2022-07-19
4
A
0
115000
0
A
2032-07-19
Common Stock
115000.0
115000
D
The option will vest as to 50% of the underlying shares on the first anniversary of the date of grant, and as to the remaining 50% of the underlying shares on the second anniversary of the date of grant.
/s/ Daniel S. Char, Attorney-in-Fact for Jonathan B. Zung
2022-10-14